Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease

Background. Although radio contrast volume has been associated with worsening post-procedural kidney function, this relationship has not been extensively studied using an iso-osmolar contrast agent in chronic kidney disease patients. Methods. We retrospectively studied patients undergoing cardiac catheterization at the University of Minnesota from 2000 to 2004, using the iso-osmolar contrast agent, iodixanol. All patients were included who had calculated creatinine clearance (CCR) < 60 mL/min, not on dialysis, and serum creatinine measured on the same day and within 7 days after the procedure. Comparison of a subgroup with severe chronic kidney disease and diabetes mellitus was compared to a similar historical control group that used the low-osmolar contrast agent, iohexol. Results. Serum creatinine and CCR were 2.9 ± 1.5 mg/dL and 33.4 ± 12.0 mL/min (mean ± standard deviation), respectively, at baseline in 117 cases. Peak creatinine increased by 0.03 ± 0.7 mg/dL after 84.3 ± 67.3 mL of iodixanol was used. Contrast-induced nephropathy definition was fulfilled in 22 (18.8%) cases. A non-significant negative correlation was found between the volume of iodixanol and the change in creatinine (r ² = 0.0011, p = 0.7254). A subgroup with severe chronic kidney disease and diabetes mellitus with iodixanol had a significantly lower creatinine increase (n = 25, 0.09 ± 0.5 mg/dL), compared to historical controls (n = 42, 0.7 ± 0.8 mg/dL) with iohexol (p < 0.001). A non-significant positive correlation between volume of contrast and change in creatinine was found in this subgroup who received iodixanol (n = 25, r ² = 0.0756, p = 0.1835), but was significant in the historical controls who received iohexol (n = 42, r ² = 0.135, p = 0.017). Conclusions. The volume of iso-osmolar radio contrast does not affect the incidence of contrast-induced nephropathy in patients with chronic kidney disease. A randomized trial evaluating the incidence of contrast nephropathy would verify the safety of ad hoc versus staged angiographic procedures in this population.